Management principles for acute illness in patients with medium-chain acyl-coenzyme a dehydrogenase deficiency

COUNCIL ON GENETICS

Research output: Contribution to journalArticlepeer-review

Abstract

Medium-chain acyl-coenzyme A dehydrogenase deficiency (MCADD) is a fatty acid oxidation disorder in which the patient is unable to break down fats to produce energy. This disorder places children at risk for metabolic decompensation during periods of stress, such as routine childhood illnesses. The intent of this clinical report is to provide pediatricians with additional information regarding the acute clinical care of patients with MCADD. Although each patient with MCADD will still be expected to have a primary metabolic physician, the involvement of the primary care provider is crucial as well. Appropriate treatment of children with MCADD can lead to avoidance of morbidity and mortality.

Original languageEnglish (US)
Article numbere2020040303
JournalPediatrics
Volume147
Issue number1
DOIs
StatePublished - Jan 1 2021

Bibliographical note

Publisher Copyright:
Copyright © 2021 by the American Academy of Pediatrics

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Management principles for acute illness in patients with medium-chain acyl-coenzyme a dehydrogenase deficiency'. Together they form a unique fingerprint.

Cite this